At Sy No. 26, Appareddypally Village, Madgul Mandal, Ranga Reddy District, Danwin Laboratories is starting a revolutionary API production plant in Telangana. The pharmaceutical sector needs 240 tonnes per year (TPA) of APIs, which this facility will create with an 8 Crore investment.
This big Telangana project will increase the state's pharmaceutical environment, generate jobs, and improve healthcare accessibility. The project's main goal is to boost India's API manufacturing capacity to meet rising demand for essential pharmaceuticals.
New production blocks, utilities, and a cutting-edge zero liquid discharge-based effluent treatment plant are built for the API manufacturing unit. Danwin Laboratories uses innovative technology and automation to produce APIs efficiently and sustainably while meeting environmental standards.
The project's schedule is unknown, although development is expected to begin soon and be operational within 1-2 years. Pharmaceutical company Danwin Laboratories supports ethical manufacture and responsible production.
Danwin Laboratories' expansion will benefit from this strategic partnership. The new API unit's emphasis on sustainable and ethical production will help drive pharmaceutical innovations and address the nation's healthcare needs.
As on December 2023, The project is now in the stage of receiving approvals. The project has received all necessary clearances.
News by Rahul Yelligetti